[Radiotherapy combined with halogenated pyrimidines--fundamental and clinical studies (author's transl)].
D000818:Animals; D002277:Carcinoma / Q000532:radiotherapy*; D002286:Carcinoma, Ehrlich Tumor / Q000532:radiotherapy; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006219:Halogens / Q000627:therapeutic use; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008441:Maxillary Neoplasms / Q000532:radiotherapy; D051379:Mice; D011743:Pyrimidines / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*
D006219:Halogens; D011743:Pyrimidines; D011838:Radiation-Sensitizing Agents; D005472:Fluorouracil